{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/49702-231#drug","name":"Triumeq","alternateName":"abacavir sulfate, dolutegravir sodium, lamivudine","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"49702-231"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA205551"},{"@type":"PropertyValue","propertyID":"UNII","value":"J220T4J9Q2|1Q1V9V5WYQ|2T8Q726O95"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"2997739a-aa91-42aa-a206-a70e2db7b84f"}],"activeIngredient":"ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"ViiV Healthcare Company"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA205551","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2997739a-aa91-42aa-a206-a70e2db7b84f","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-231"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T17:09:38.387Z"}}